Literature DB >> 21488146

Cholesteryl ester transfer protein: the controversial relation to atherosclerosis and emerging new biological roles.

Helena C F Oliveira1, Eliana C de Faria.   

Abstract

Cholesteryl ester transfer protein (CETP) exerts a profound impact on high-density lipoprotein (HDL) metabolism and, consequently, on the risk of atherosclerosis development and cardiovascular mortality. Here, we review the complex relationship between CETP and atherosclerosis based upon the experimental, clinical, and epidemiological studies. In addition, we discuss the recent findings that expand the functions of CETP to new areas of interest such as Alzheimer's disease, inflammation, and obesity.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21488146     DOI: 10.1002/iub.448

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  19 in total

1.  The lipid transfer properties of CETP define the concentration and composition of plasma lipoproteins.

Authors:  Richard E Morton; Yan Liu
Journal:  J Lipid Res       Date:  2020-06-26       Impact factor: 5.922

2.  Apolipoprotein F: a natural inhibitor of cholesteryl ester transfer protein and a key regulator of lipoprotein metabolism.

Authors:  Yan Liu; Richard E Morton
Journal:  Curr Opin Lipidol       Date:  2020-08       Impact factor: 4.776

3.  Modification of CETP function by changing its substrate preference: a new paradigm for CETP drug design.

Authors:  Richard E Morton; Lahoucine Izem
Journal:  J Lipid Res       Date:  2015-01-23       Impact factor: 5.922

Review 4.  HDL--is it too big to fail?

Authors:  Dominic S Ng; Norman C W Wong; Robert A Hegele
Journal:  Nat Rev Endocrinol       Date:  2013-01-15       Impact factor: 43.330

5.  ApoF knockdown increases cholesteryl ester transfer to LDL and impairs cholesterol clearance in fat-fed hamsters.

Authors:  Richard E Morton; Yan Liu; Lahoucine Izem
Journal:  J Lipid Res       Date:  2019-09-11       Impact factor: 5.922

6.  Genetic markers of cholesterol transport and gray matter diffusion: a preliminary study of the CETP I405V polymorphism.

Authors:  Lauren E Salminen; Peter R Schofield; Kerrie D Pierce; Xi Luo; Yi Zhao; David H Laidlaw; Ryan P Cabeen; Thomas E Conturo; Elizabeth M Lane; Jodi M Heaps; Jacob D Bolzenius; Laurie M Baker; Sarah A Cooley; Staci Scott; Lee M Cagle; Robert H Paul
Journal:  J Neural Transm (Vienna)       Date:  2015-08-08       Impact factor: 3.575

7.  Chronic Exercise Reduces CETP and Mesterolone Treatment Counteracts Exercise Benefits on Plasma Lipoproteins Profile: Studies in Transgenic Mice.

Authors:  Andrea Camargo Casquero; Jairo Augusto Berti; Laura Lauand Sampaio Teixeira; Helena Coutinho Franco de Oliveira
Journal:  Lipids       Date:  2017-10-20       Impact factor: 1.880

8.  Exon 9-deleted CETP inhibits full length-CETP synthesis and promotes cellular triglyceride storage.

Authors:  Lahoucine Izem; Yan Liu; Richard E Morton
Journal:  J Lipid Res       Date:  2020-01-27       Impact factor: 5.922

Review 9.  Patient considerations and clinical impact of cholesteryl ester transfer protein inhibitors in the management of dyslipidemia: focus on anacetrapib.

Authors:  Marta A Miyares; Kyle Davis
Journal:  Vasc Health Risk Manag       Date:  2012-08-23

10.  The I405V and Taq1B polymorphisms of the CETP gene differentially affect sub-clinical carotid atherosclerosis.

Authors:  Eliane Soler Parra; Natália Baratella Panzoldo; Denise Kaplan; Helena Coutinho Franco de Oliveira; José Ernesto dos Santos; Luiz Sérgio Fernandes de Carvalho; Andrei Carvalho Sposito; Magnus Gidlund; Ruy Tsutomu Nakamura; Vanessa Helena de Souza Zago; Edna Regina Nakandakare; Eder Carlos Rocha Quintão; Eliana Cotta de Faria
Journal:  Lipids Health Dis       Date:  2012-10-05       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.